secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0000950142-23-000586
Event type: other_material
Sentiment:  positive
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharma shareholders approve stock issuance to Streeterville Capital
-----------------------------------------------------------------------

- Stockholders approved issuance of common shares to Streeterville Capital, LLC under Nasdaq Listing Rule 5635(d).
- Vote results: 38,338,555 for, 311,870 against, 373,843 abstentions.
- Special meeting reconvened on March 3, 2023, with quorum present throughout.
- Approval allows company to proceed with share issuance, potentially for financing or debt conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/0000950142-23-000586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000095014223000586/eh230336011_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950142-23-000586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer